-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Invivoscribe: Partnering with Pharma to Streamline Oncological Clinical Development

Sponsor: Invivoscribe, Inc
Program: Company Showcases
Hematology Disease Topics & Pathways:
Diseases, Lymphoid Malignancies, Myeloid Malignancies, Measurable Residual Disease
Saturday, December 7, 2024: 1:30 PM-1:45 PM
Room 5B (San Diego Convention Center)
Speaker:
Jason Gerhold, Invivoscribe, Inc.
Disclosures:
No relevant conflicts of interest to declare.

For in-person participants only
See more of: Company Showcases
<< Previous Session | Next Session >>